Clinical trial
Fetched
Post
clinicaltrials.gov
Jazz Pharmaceuticals, GW Research
(2023).
A Study of JZP541 in Adults With Irritability Associated With Autism Spectrum Disorder.
ClinicalTrials.gov.
Jazz Pharmaceuticals.
- Publication date
-
30 Jun 2023
- Identifier
-
NCT05733390
- Authors
-
Jazz Pharmaceuticals,
GW Research
- Source
- ClinicalTrials.gov
- Reference type
- clinical_trial
- Publisher
- Jazz Pharmaceuticals
- Metadata source
- clinicaltrials.gov
Abstract
Behavior dysregulation is commonly associated with people with autism spectrum disorder (ASD). Irritability is a major safety concern in adults with ASD. This study will assess the efficacy and safety of JZP541 in the treatment of adults with irritability associated with ASD.